Australia's first preclinical contract R&D facility, TetraQ, was officially launched today to help speed the movement of medicines out of the laboratory and into the marketplace.

Austrian company Intercell has announced the completion of the phase I study of its Staphylococcus aureus vaccine.

An international research consortium has identified four genes believed to increase susceptibility to breast cancer. [ + ]

The Lomb Group has recently been appointed the national distributor for the Eppendorf range of products.

The government has introduced the Global Opportunities program, promising $254.1 million over 10 years to help Australian companies become global businesses.

The Australian Institute for Commercialisation (AIC) and the Australian Nano Business Forum (ANBF) have combined to help raise industry awareness of the potential of nanotechnology.

Scientists from New Zealand and Australia have used mountains as giant ‘dipsticks’ to analyse the history of the world's largest ice sheet.

The hunt for Wobbly is on. [ + ]

US researchers have constructed the first family tree of metabolic protein architecture. [ + ]

Geron scientists and collaborators differentiate human embryonic stem cells into insulin-producing islet-like clusters. [ + ]

Five biologists are amongst the 20 Federation Fellows named for 2007. [ + ]

Scientific Solutions has reached a distribution agreement with the US company, Gamry Instruments.

Two respected chemists across the world from one another will share the 2007 Welch Award in Chemistry, bestowed for their achievements in theoretical chemistry.

p53, the gene thought to be essential in helping chemotherapy kill cancer cells, may actually help them thrive. [ + ]

A Queensland PhD student has come up with a rapid diagnostic test for Dengue fever. [ + ]